Eisai Pharmaceuticals India
Dr. Neeraj Kumar is an accomplished professional with extensive experience in the pharmaceutical industry. Currently serving as the APi solution business leader at Eisai Pharmaceuticals India since December 2014, Dr. Kumar has previously held the position of Research Department Specialist at Cipla from December 2014 to June 2021, focusing on research and development as well as technology transfer. Prior to this, Dr. Kumar was the Group Project Lead at Cadila Pharmaceuticals Limited from June 2008 to June 2014, leading research and development efforts for generic molecules. Dr. Kumar holds a Doctor of Philosophy in Organic Medicinal Chemistry and a master's degree in the same field.
This person is not in any offices
Eisai Pharmaceuticals India
2 followers
Welcome to Eisai India. Eisai (pronounced 'ā-zī’) is derived from the Japanese word for 'health product' and, here at Eisai, we discover, develop and market innovative, high quality medicines throughout the world. Eisai is one of the world's leading research-based pharmaceutical companies. With operations in the U.S., Asia, Europe, Russia, India, Africa, the Middle East, Australia and it's domestic home market of Japan, Eisai employs more than 11,000 people worldwide. Eisai Pharmaceuticals India Pvt. Ltd. (Eisai India) was incorporated in October 2004, with registered office at Mumbai. Eisai Co.,Ltd was the first Japanese company to have a 100% subsidiary in Indian pharmaceutical market. Eisai India product portfolio includes prescription medicines in several therapeutic areas such as central nervous system disorders, metastatic breast cancer, benign prostrate hyperplasia , muscle spasm, vertigo, gastrointestinal disorders, diabetes and peripheral neuropathy. Eisai India has a dedicated team of well-trained 200 field force across the country under various specialties and more than 250 employees across Research and Manufacturing. We continuously work with Medical Doctors and the Healthcare professionals in India to ensure that they have updated information on our products so that they can prescribe the best products for the health care needs of their patients. Eisai India’s integrated Manufacturing and Research facility at Visakhapatnam (Vizag), Andhra Pradesh stimulates knowledge creation between teams – from those who create products through research, to those who produce - by bringing them together on one site and is supplemented by the necessary support functions. Eisai India’s Vizag facility manufactures Drug Substances (Active Pharmaceutical Ingredients-APIs), Drug Products (Oral solid dosage forms-Tablets) and carries out Developmental Research of Active Pharmaceutical Ingredients (APIs).This facility is registered as a pharmaceutical manufacturer at regulatory agencies viz USFDA, PMDA, MHRA and WHO. Research labs at Vizag facility are recognized by the Department of scientific and industrial research (DSIR). Facility also received the Certification of ISO 14001:2004 for Environment management system (EMS), OHSAS 18001 for Occupational Health and Safety Series and ISO 27001 for Information security management system from TUV SUD.